查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1179738

菸鹼醯胺市場:各類型，各用途，各流通管道:全球機會分析及產業預測，2021-2031年

Niacinamide Market By Type, By Application, By Distribution Channel : Global Opportunity Analysis and Industry Forecast, 2021-2031
出版日期: | 出版商: Allied Market Research | 英文 315 Pages | 商品交期: 2-3個工作天內

價格

菸鹼醯胺的全球市場2021年為5億4608萬美元，2031年預計達到8億3241萬美元，從2022年到2031年的年複合成長率記錄4.3％。

菸鹼醯胺是維他命B3的一種形式，是人體必需的營養素。維生素B3缺乏會導致皮膚病、腎臟和腦部疾病，這些疾病可以服用菸鹼醯胺產品和補充劑來治療。

提高對菸鹼醯胺益處的認識、化妝品使用量的增加以及研發活動的增加和投資是導致市場增長的關鍵驅動因素。頂級市場參與者正在投資研發活動，以開發新的含煙醯胺產品。此外，產品發布和建立強大的產品組合是參與者的主要關注點。長期使用煙醯胺相關的副作用會影響產品的銷售並阻礙市場的成長。

目錄

第1章 簡介

第2章 摘要整理

第3章 市場概要

  • 市場定義和範圍
  • 主要調查結果
    • 主要的投資口袋
  • 波特的五力分析
  • 主要企業的定位
  • 市場動態
    • 促進因素
    • 阻礙因素
    • 機會
  • COVID-19 影響分析
  • 專利形勢

第4章 菸鹼醯胺市場:各類型

  • 概要
    • 市場規模及預測
  • 粉狀體
    • 主要的市場趨勢，成長要素，機會
    • 市場規模、預測:各地區
    • 市場分析:各國分析
    • 粉末菸鹼醯胺市場:各類型
      • 天然物的市場規模及預測:各地區
      • 合成的市場規模、預測:各地區
  • 液體
    • 主要的市場趨勢，成長要素，機會
    • 市場規模、預測:各地區
    • 市場分析:各國
  • 其他
    • 主要的市場趨勢，成長要素，機會
    • 市場規模、預測:各地區
    • 市場分析:各國

第5章 菸鹼醯胺市場:各用途

  • 概要
    • 市場規模及預測
  • 醫藥品
    • 主要的市場趨勢，成長要素與機會
    • 市場規模、預測:各地區
    • 市場分析:各國
  • 藥用化妝品
    • 主要的市場趨勢，成長要素，機會
    • 市場規模、預測:各地區
    • 市場分析:各國
  • 人的營養
    • 主要的市場趨勢，成長要素，機會
    • 市場規模、預測:各地區
    • 市場分析:各國

第6章 菸鹼醯胺市場:各流通管道

  • 概要
    • 市場規模及預測
  • 醫院藥局
    • 主要的市場趨勢，成長要素與機會
    • 市場規模、預測:各地區
    • 市場分析:各國
  • 線上藥局
    • 主要的市場趨勢，成長要素，機會
    • 市場規模、預測:各地區
    • 市場分析:各國
  • 藥妝店、零售藥局
    • 主要的市場趨勢，成長要素，機會
    • 市場規模、預測:各地區
    • 市場分析:各國

第7章 菸鹼醯胺市場:各地區

  • 概要
    • 市場規模及預測
  • 北美
    • 主要趨勢和機會
    • 北美的市場規模、預測:各類型
      • 北美的粉末菸鹼醯胺市場:各類型
    • 北美的市場規模、預測:各用途
    • 北美市場規模、預測:各流通管道
    • 北美市場規模、預測:各國
      • 美國
      • 加拿大
      • 墨西哥
  • 歐洲
    • 主要趨勢和機會
    • 歐洲的市場規模、預測:各類型
      • 粉末菸鹼醯胺的歐洲市場:各類型
    • 歐洲市場規模、預測:各用途
    • 歐洲市場規模、預測:各流通管道
    • 歐洲市場規模、預測:各國
      • 德國
      • 法國
      • 英國
      • 義大利
      • 西班牙
      • 其他歐洲
  • 亞太地區
    • 主要趨勢和機會
    • 亞太地區的市場規模、預測:各類型
      • 亞太地區的粉末菸鹼醯胺市場:各類型
    • 亞太地區的市場規模、預測:各用途
    • 亞太地區的市場規模、預測:各流通管道
    • 亞太地區的市場規模、預測:各國
      • 日本
      • 中國
      • 澳洲
      • 印度
      • 韓國
      • 其他亞太地區
  • LAMEA
    • 主要趨勢和機會
    • LAMEA的市場規模、預測:各類型
      • LAMEA的粉末菸鹼醯胺市場:各類型
    • LAMEA的市場規模、預測:各應用領域
    • LAMEA的市場規模、預測:各流通管道
    • LAMEA的市場規模、預測:各國
      • 巴西
      • 沙烏地阿拉伯
      • 南非
      • LAMEA的其餘地區

第8章 企業形勢

  • 簡介
  • 主要成功策略
  • 主要十大公司的產品製圖
  • 競爭儀表板
  • 競爭的熱圖
  • 主要的發展

第9章 企業簡介

  • Brother Enterprises Holding Co., Ltd
  • Evonik Industries AG
  • Fagron Inc.
  • Foodchem International
  • Glossier
  • Jubilant Life Sciences Limited
  • Koninklijke DSM N.V
  • Lasons India Pvt Ltd
  • Lonza Group
  • Merck KGAA
  • Veer Chemie
  • Vertellus
Product Code: A17530

The global niacinamide market was valued at $546.08 million in 2021, and is projected to reach $832.41 million by 2031, registering a CAGR of 4.3% from 2022 to 2031.

Niacinamide, a form of vitamin B3, is an essential nutrient in human body. Vitamin B3 deficiency can lead to skin disorders, kidney, and brain diseases, which can be treated by administering niacinamide products and supplements. Niacinamide can be obtained both naturally and synthetically. Naturally it is obtained from both beef and chicken livers and from eggs, fish, meat, and green vegetables. Synthetically it is produced by hydrolysis of nicotinonitrile, which is catalyzed by the enzyme nitrile hydratase from Rhodococcus rhodochrous.

World Health Organization (WHO) states that skin diseases are among the most common of all human health conditions and affects almost 900 million people in the world at any time. This skin conditions can be well treated by using niacinamide which includes reducing redness from eczema, acne, and other inflammatory skin conditions. In addition, it is used to prevent dermatological conditions, including autoimmune blistering disorders, acne, rosacea, ageing skin, and atopic dermatitis. Hence, owing to these applications, there is a greater demand for the drug in the cosmeceuticals sector, which propels growth of the market. Niacin has long been used to lower triglycerides and increase high-density lipoprotein (HDL) cholesterol. This further highlights its demand in the pharmaceuticals segment causing increase in sales of products.

In addition, vitamin B3 enhances digestive health in dairy cattle, which prevents metabolic diseases. According to the U.S. department of agriculture, supplementation of 12g of niacin per head per day can increase milk production by about 1lb. This further propels increase in demand for niacinamide for animals to enhance their digestive health. For instance, Niacin RP is the niacinamide nutrition developed by Jubilant Ingrevia, which is expected to propel the market growth.

Increase in awareness regarding benefits of niacinamide, rise in usage of cosmetic products, and rise and investments in research & development activities are the key drivers that lead to growth of the market. Top market players are investing in research and development activities to develop new niacinamide containing products. In addition, product launch and building a strong product portfolio is the major focus of the players. In addition, increasing consumer awareness and concerns about health benefits provides opportunities to the market players to manufacture products which have proven to be highly effective. Along with this, the growing prevalence of the skin related diseases, increasing vitamin B3 deficiency cases around the globe and increasing awareness among the people regarding the consumption of healthy food supplements provides a favorable environment for increasing sales of niacinamide products and for growth of the overall market. Furthermore, side effects associated with long-term use of niacinamide can affect sales of the products and hinder growth of the market.

The niacinamide market is segmented on the basis of type, application, distribution channel, and region. By type, it is divided into powder, liquid, and others. Further, the powder segment is divided into natural and synthetic. On the basis of application, the market is segmented into pharmaceutical, cosmeceutical, and human nutrition. According to the distribution channel, it is segmented into hospital pharmacies, online pharmacies, and drug stores & retail pharmacies. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Major companies profiled in this report include Brother Enterprises Holding Co., Ltd, Evonik Industries AG, Fagron Inc, Foodchem International Corporation, Glossier, Jubilant Life Sciences Limited, Koninklijke DSM N.V, Lasons India Pvt Ltd, Lonza Group, Merck KGAA, and Veer Chemie, Vertellus.

Key Benefits For Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the niacinamide market analysis from 2021 to 2031 to identify the prevailing niacinamide market opportunities.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the niacinamide market segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global niacinamide market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments

By Type

  • Powder
    • Type
    • Natural
    • Synthetic
  • Liquid
  • Others

By Application

  • Pharmaceutical
  • Cosmeceutical
  • Human Nutrition

By Distribution Channel

  • Hospital Pharmacies
  • Online Pharmacies
  • Drug stores and Retail Pharmacies

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest Of Europe
  • Asia-Pacific
    • Japan
    • China
    • Australia
    • India
    • South Korea
    • Rest Of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest Of LAMEA
  • Key Market Players
    • Brother Enterprises Holding Co., Ltd
    • Evonik Industries AG
    • Fagron Inc.
    • Foodchem International
    • Glossier
    • Jubilant Life Sciences Limited
    • Koninklijke DSM N.V
    • Lasons India Pvt Ltd
    • Lonza Group
    • Merck KGAA
    • Veer Chemie
    • Vertellus

TABLE OF CONTENTS

CHAPTER 1:INTRODUCTION

  • 1.1.Report description
  • 1.2.Key market segments
  • 1.3.Key benefits to the stakeholders
  • 1.4.Research Methodology
    • 1.4.1.Secondary research
    • 1.4.2.Primary research
    • 1.4.3.Analyst tools and models

CHAPTER 2:EXECUTIVE SUMMARY

  • 2.1.Key findings of the study
  • 2.2.CXO Perspective

CHAPTER 3:MARKET OVERVIEW

  • 3.1.Market definition and scope
  • 3.2.Key findings
    • 3.2.1.Top investment pockets
  • 3.3.Porter's five forces analysis
  • 3.4.Top player positioning
  • 3.5.Market dynamics
    • 3.5.1.Drivers
    • 3.5.2.Restraints
    • 3.5.3.Opportunities
  • 3.6.COVID-19 Impact Analysis on the market
  • 3.7.Patent Landscape

CHAPTER 4: NIACINAMIDE MARKET, BY TYPE

  • 4.1 Overview
    • 4.1.1 Market size and forecast
  • 4.2 Powder
    • 4.2.1 Key market trends, growth factors and opportunities
    • 4.2.2 Market size and forecast, by region
    • 4.2.3 Market analysis by country
    • 4.2.4 Powder Niacinamide Market by Type
      • 4.2.4.1 Natural Market size and forecast, by region
      • 4.2.4.2 Synthetic Market size and forecast, by region
  • 4.3 Liquid
    • 4.3.1 Key market trends, growth factors and opportunities
    • 4.3.2 Market size and forecast, by region
    • 4.3.3 Market analysis by country
  • 4.4 Others
    • 4.4.1 Key market trends, growth factors and opportunities
    • 4.4.2 Market size and forecast, by region
    • 4.4.3 Market analysis by country

CHAPTER 5: NIACINAMIDE MARKET, BY APPLICATION

  • 5.1 Overview
    • 5.1.1 Market size and forecast
  • 5.2 Pharmaceutical
    • 5.2.1 Key market trends, growth factors and opportunities
    • 5.2.2 Market size and forecast, by region
    • 5.2.3 Market analysis by country
  • 5.3 Cosmeceutical
    • 5.3.1 Key market trends, growth factors and opportunities
    • 5.3.2 Market size and forecast, by region
    • 5.3.3 Market analysis by country
  • 5.4 Human Nutrition
    • 5.4.1 Key market trends, growth factors and opportunities
    • 5.4.2 Market size and forecast, by region
    • 5.4.3 Market analysis by country

CHAPTER 6: NIACINAMIDE MARKET, BY DISTRIBUTION CHANNEL

  • 6.1 Overview
    • 6.1.1 Market size and forecast
  • 6.2 Hospital Pharmacies
    • 6.2.1 Key market trends, growth factors and opportunities
    • 6.2.2 Market size and forecast, by region
    • 6.2.3 Market analysis by country
  • 6.3 Online Pharmacies
    • 6.3.1 Key market trends, growth factors and opportunities
    • 6.3.2 Market size and forecast, by region
    • 6.3.3 Market analysis by country
  • 6.4 Drug stores and Retail Pharmacies
    • 6.4.1 Key market trends, growth factors and opportunities
    • 6.4.2 Market size and forecast, by region
    • 6.4.3 Market analysis by country

CHAPTER 7: NIACINAMIDE MARKET, BY REGION

  • 7.1 Overview
    • 7.1.1 Market size and forecast
  • 7.2 North America
    • 7.2.1 Key trends and opportunities
    • 7.2.2 North America Market size and forecast, by Type
      • 7.2.2.1 North America Powder Niacinamide Market by Type
    • 7.2.3 North America Market size and forecast, by Application
    • 7.2.4 North America Market size and forecast, by Distribution Channel
    • 7.2.5 North America Market size and forecast, by country
      • 7.2.5.1 U.S.
      • 7.2.5.1.1 Market size and forecast, by Type
      • 7.2.5.1.2 Market size and forecast, by Application
      • 7.2.5.1.3 Market size and forecast, by Distribution Channel
      • 7.2.5.2 Canada
      • 7.2.5.2.1 Market size and forecast, by Type
      • 7.2.5.2.2 Market size and forecast, by Application
      • 7.2.5.2.3 Market size and forecast, by Distribution Channel
      • 7.2.5.3 Mexico
      • 7.2.5.3.1 Market size and forecast, by Type
      • 7.2.5.3.2 Market size and forecast, by Application
      • 7.2.5.3.3 Market size and forecast, by Distribution Channel
  • 7.3 Europe
    • 7.3.1 Key trends and opportunities
    • 7.3.2 Europe Market size and forecast, by Type
      • 7.3.2.1 Europe Powder Niacinamide Market by Type
    • 7.3.3 Europe Market size and forecast, by Application
    • 7.3.4 Europe Market size and forecast, by Distribution Channel
    • 7.3.5 Europe Market size and forecast, by country
      • 7.3.5.1 Germany
      • 7.3.5.1.1 Market size and forecast, by Type
      • 7.3.5.1.2 Market size and forecast, by Application
      • 7.3.5.1.3 Market size and forecast, by Distribution Channel
      • 7.3.5.2 France
      • 7.3.5.2.1 Market size and forecast, by Type
      • 7.3.5.2.2 Market size and forecast, by Application
      • 7.3.5.2.3 Market size and forecast, by Distribution Channel
      • 7.3.5.3 UK
      • 7.3.5.3.1 Market size and forecast, by Type
      • 7.3.5.3.2 Market size and forecast, by Application
      • 7.3.5.3.3 Market size and forecast, by Distribution Channel
      • 7.3.5.4 Italy
      • 7.3.5.4.1 Market size and forecast, by Type
      • 7.3.5.4.2 Market size and forecast, by Application
      • 7.3.5.4.3 Market size and forecast, by Distribution Channel
      • 7.3.5.5 Spain
      • 7.3.5.5.1 Market size and forecast, by Type
      • 7.3.5.5.2 Market size and forecast, by Application
      • 7.3.5.5.3 Market size and forecast, by Distribution Channel
      • 7.3.5.6 Rest of Europe
      • 7.3.5.6.1 Market size and forecast, by Type
      • 7.3.5.6.2 Market size and forecast, by Application
      • 7.3.5.6.3 Market size and forecast, by Distribution Channel
  • 7.4 Asia-Pacific
    • 7.4.1 Key trends and opportunities
    • 7.4.2 Asia-Pacific Market size and forecast, by Type
      • 7.4.2.1 Asia-Pacific Powder Niacinamide Market by Type
    • 7.4.3 Asia-Pacific Market size and forecast, by Application
    • 7.4.4 Asia-Pacific Market size and forecast, by Distribution Channel
    • 7.4.5 Asia-Pacific Market size and forecast, by country
      • 7.4.5.1 Japan
      • 7.4.5.1.1 Market size and forecast, by Type
      • 7.4.5.1.2 Market size and forecast, by Application
      • 7.4.5.1.3 Market size and forecast, by Distribution Channel
      • 7.4.5.2 China
      • 7.4.5.2.1 Market size and forecast, by Type
      • 7.4.5.2.2 Market size and forecast, by Application
      • 7.4.5.2.3 Market size and forecast, by Distribution Channel
      • 7.4.5.3 Australia
      • 7.4.5.3.1 Market size and forecast, by Type
      • 7.4.5.3.2 Market size and forecast, by Application
      • 7.4.5.3.3 Market size and forecast, by Distribution Channel
      • 7.4.5.4 India
      • 7.4.5.4.1 Market size and forecast, by Type
      • 7.4.5.4.2 Market size and forecast, by Application
      • 7.4.5.4.3 Market size and forecast, by Distribution Channel
      • 7.4.5.5 South Korea
      • 7.4.5.5.1 Market size and forecast, by Type
      • 7.4.5.5.2 Market size and forecast, by Application
      • 7.4.5.5.3 Market size and forecast, by Distribution Channel
      • 7.4.5.6 Rest of Asia-Pacific
      • 7.4.5.6.1 Market size and forecast, by Type
      • 7.4.5.6.2 Market size and forecast, by Application
      • 7.4.5.6.3 Market size and forecast, by Distribution Channel
  • 7.5 LAMEA
    • 7.5.1 Key trends and opportunities
    • 7.5.2 LAMEA Market size and forecast, by Type
      • 7.5.2.1 LAMEA Powder Niacinamide Market by Type
    • 7.5.3 LAMEA Market size and forecast, by Application
    • 7.5.4 LAMEA Market size and forecast, by Distribution Channel
    • 7.5.5 LAMEA Market size and forecast, by country
      • 7.5.5.1 Brazil
      • 7.5.5.1.1 Market size and forecast, by Type
      • 7.5.5.1.2 Market size and forecast, by Application
      • 7.5.5.1.3 Market size and forecast, by Distribution Channel
      • 7.5.5.2 Saudi Arabia
      • 7.5.5.2.1 Market size and forecast, by Type
      • 7.5.5.2.2 Market size and forecast, by Application
      • 7.5.5.2.3 Market size and forecast, by Distribution Channel
      • 7.5.5.3 South Africa
      • 7.5.5.3.1 Market size and forecast, by Type
      • 7.5.5.3.2 Market size and forecast, by Application
      • 7.5.5.3.3 Market size and forecast, by Distribution Channel
      • 7.5.5.4 Rest of LAMEA
      • 7.5.5.4.1 Market size and forecast, by Type
      • 7.5.5.4.2 Market size and forecast, by Application
      • 7.5.5.4.3 Market size and forecast, by Distribution Channel

CHAPTER 8: COMPANY LANDSCAPE

  • 8.1. Introduction
  • 8.2. Top winning strategies
  • 8.3. Product Mapping of Top 10 Player
  • 8.4. Competitive Dashboard
  • 8.5. Competitive Heatmap
  • 8.6. Key developments

CHAPTER 9: COMPANY PROFILES

  • 9.1 Brother Enterprises Holding Co., Ltd
    • 9.1.1 Company overview
    • 9.1.2 Company snapshot
    • 9.1.3 Operating business segments
    • 9.1.4 Product portfolio
    • 9.1.5 Business performance
    • 9.1.6 Key strategic moves and developments
  • 9.2 Evonik Industries AG
    • 9.2.1 Company overview
    • 9.2.2 Company snapshot
    • 9.2.3 Operating business segments
    • 9.2.4 Product portfolio
    • 9.2.5 Business performance
    • 9.2.6 Key strategic moves and developments
  • 9.3 Fagron Inc.
    • 9.3.1 Company overview
    • 9.3.2 Company snapshot
    • 9.3.3 Operating business segments
    • 9.3.4 Product portfolio
    • 9.3.5 Business performance
    • 9.3.6 Key strategic moves and developments
  • 9.4 Foodchem International
    • 9.4.1 Company overview
    • 9.4.2 Company snapshot
    • 9.4.3 Operating business segments
    • 9.4.4 Product portfolio
    • 9.4.5 Business performance
    • 9.4.6 Key strategic moves and developments
  • 9.5 Glossier
    • 9.5.1 Company overview
    • 9.5.2 Company snapshot
    • 9.5.3 Operating business segments
    • 9.5.4 Product portfolio
    • 9.5.5 Business performance
    • 9.5.6 Key strategic moves and developments
  • 9.6 Jubilant Life Sciences Limited
    • 9.6.1 Company overview
    • 9.6.2 Company snapshot
    • 9.6.3 Operating business segments
    • 9.6.4 Product portfolio
    • 9.6.5 Business performance
    • 9.6.6 Key strategic moves and developments
  • 9.7 Koninklijke DSM N.V
    • 9.7.1 Company overview
    • 9.7.2 Company snapshot
    • 9.7.3 Operating business segments
    • 9.7.4 Product portfolio
    • 9.7.5 Business performance
    • 9.7.6 Key strategic moves and developments
  • 9.8 Lasons India Pvt Ltd
    • 9.8.1 Company overview
    • 9.8.2 Company snapshot
    • 9.8.3 Operating business segments
    • 9.8.4 Product portfolio
    • 9.8.5 Business performance
    • 9.8.6 Key strategic moves and developments
  • 9.9 Lonza Group
    • 9.9.1 Company overview
    • 9.9.2 Company snapshot
    • 9.9.3 Operating business segments
    • 9.9.4 Product portfolio
    • 9.9.5 Business performance
    • 9.9.6 Key strategic moves and developments
  • 9.10 Merck KGAA
    • 9.10.1 Company overview
    • 9.10.2 Company snapshot
    • 9.10.3 Operating business segments
    • 9.10.4 Product portfolio
    • 9.10.5 Business performance
    • 9.10.6 Key strategic moves and developments
  • 9.11 Veer Chemie
    • 9.11.1 Company overview
    • 9.11.2 Company snapshot
    • 9.11.3 Operating business segments
    • 9.11.4 Product portfolio
    • 9.11.5 Business performance
    • 9.11.6 Key strategic moves and developments
  • 9.12 Vertellus
    • 9.12.1 Company overview
    • 9.12.2 Company snapshot
    • 9.12.3 Operating business segments
    • 9.12.4 Product portfolio
    • 9.12.5 Business performance
    • 9.12.6 Key strategic moves and developments

LIST OF TABLES

  • TABLE 1. GLOBAL NIACINAMIDE MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 2. NIACINAMIDE MARKET, FOR POWDER, BY REGION, 2021-2031 ($MILLION)
  • TABLE 3. NIACINAMIDE MARKET FOR POWDER, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 4. GLOBAL POWDER NIACINAMIDE MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 5. NIACINAMIDE MARKET, FOR NATURAL, BY REGION, 2021-2031 ($MILLION)
  • TABLE 6. NIACINAMIDE MARKET, FOR SYNTHETIC, BY REGION, 2021-2031 ($MILLION)
  • TABLE 7. NIACINAMIDE MARKET, FOR LIQUID, BY REGION, 2021-2031 ($MILLION)
  • TABLE 8. NIACINAMIDE MARKET FOR LIQUID, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 9. NIACINAMIDE MARKET, FOR OTHERS, BY REGION, 2021-2031 ($MILLION)
  • TABLE 10. NIACINAMIDE MARKET FOR OTHERS, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 11. GLOBAL NIACINAMIDE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 12. NIACINAMIDE MARKET, FOR PHARMACEUTICAL, BY REGION, 2021-2031 ($MILLION)
  • TABLE 13. NIACINAMIDE MARKET FOR PHARMACEUTICAL, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 14. NIACINAMIDE MARKET, FOR COSMECEUTICAL, BY REGION, 2021-2031 ($MILLION)
  • TABLE 15. NIACINAMIDE MARKET FOR COSMECEUTICAL, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 16. NIACINAMIDE MARKET, FOR HUMAN NUTRITION, BY REGION, 2021-2031 ($MILLION)
  • TABLE 17. NIACINAMIDE MARKET FOR HUMAN NUTRITION, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 18. GLOBAL NIACINAMIDE MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
  • TABLE 19. NIACINAMIDE MARKET, FOR HOSPITAL PHARMACIES, BY REGION, 2021-2031 ($MILLION)
  • TABLE 20. NIACINAMIDE MARKET FOR HOSPITAL PHARMACIES, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 21. NIACINAMIDE MARKET, FOR ONLINE PHARMACIES, BY REGION, 2021-2031 ($MILLION)
  • TABLE 22. NIACINAMIDE MARKET FOR ONLINE PHARMACIES, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 23. NIACINAMIDE MARKET, FOR DRUG STORES AND RETAIL PHARMACIES, BY REGION, 2021-2031 ($MILLION)
  • TABLE 24. NIACINAMIDE MARKET FOR DRUG STORES AND RETAIL PHARMACIES, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 25. NIACINAMIDE MARKET, BY REGION, 2021-2031 ($MILLION)
  • TABLE 26. NORTH AMERICA NIACINAMIDE MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 27. NORTH AMERICA POWDER NIACINAMIDE MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 28. NORTH AMERICA NIACINAMIDE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 29. NORTH AMERICA NIACINAMIDE MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
  • TABLE 30. NORTH AMERICA NIACINAMIDE MARKET, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 31. U.S. NIACINAMIDE MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 32. U.S. NIACINAMIDE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 33. U.S. NIACINAMIDE MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
  • TABLE 34. CANADA NIACINAMIDE MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 35. CANADA NIACINAMIDE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 36. CANADA NIACINAMIDE MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
  • TABLE 37. MEXICO NIACINAMIDE MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 38. MEXICO NIACINAMIDE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 39. MEXICO NIACINAMIDE MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
  • TABLE 40. EUROPE NIACINAMIDE MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 41. EUROPE POWDER NIACINAMIDE MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 42. EUROPE NIACINAMIDE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 43. EUROPE NIACINAMIDE MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
  • TABLE 44. EUROPE NIACINAMIDE MARKET, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 45. GERMANY NIACINAMIDE MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 46. GERMANY NIACINAMIDE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 47. GERMANY NIACINAMIDE MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
  • TABLE 48. FRANCE NIACINAMIDE MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 49. FRANCE NIACINAMIDE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 50. FRANCE NIACINAMIDE MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
  • TABLE 51. UK NIACINAMIDE MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 52. UK NIACINAMIDE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 53. UK NIACINAMIDE MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
  • TABLE 54. ITALY NIACINAMIDE MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 55. ITALY NIACINAMIDE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 56. ITALY NIACINAMIDE MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
  • TABLE 57. SPAIN NIACINAMIDE MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 58. SPAIN NIACINAMIDE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 59. SPAIN NIACINAMIDE MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
  • TABLE 60. REST OF EUROPE NIACINAMIDE MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 61. REST OF EUROPE NIACINAMIDE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 62. REST OF EUROPE NIACINAMIDE MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
  • TABLE 63. ASIA-PACIFIC NIACINAMIDE MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 64. ASIA-PACIFIC POWDER NIACINAMIDE MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 65. ASIA-PACIFIC NIACINAMIDE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 66. ASIA-PACIFIC NIACINAMIDE MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
  • TABLE 67. ASIA-PACIFIC NIACINAMIDE MARKET, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 68. JAPAN NIACINAMIDE MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 69. JAPAN NIACINAMIDE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 70. JAPAN NIACINAMIDE MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
  • TABLE 71. CHINA NIACINAMIDE MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 72. CHINA NIACINAMIDE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 73. CHINA NIACINAMIDE MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
  • TABLE 74. AUSTRALIA NIACINAMIDE MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 75. AUSTRALIA NIACINAMIDE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 76. AUSTRALIA NIACINAMIDE MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
  • TABLE 77. INDIA NIACINAMIDE MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 78. INDIA NIACINAMIDE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 79. INDIA NIACINAMIDE MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
  • TABLE 80. SOUTH KOREA NIACINAMIDE MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 81. SOUTH KOREA NIACINAMIDE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 82. SOUTH KOREA NIACINAMIDE MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
  • TABLE 83. REST OF ASIA-PACIFIC NIACINAMIDE MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 84. REST OF ASIA-PACIFIC NIACINAMIDE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 85. REST OF ASIA-PACIFIC NIACINAMIDE MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
  • TABLE 86. LAMEA NIACINAMIDE MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 87. LAMEA POWDER NIACINAMIDE MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 88. LAMEA NIACINAMIDE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 89. LAMEA NIACINAMIDE MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
  • TABLE 90. LAMEA NIACINAMIDE MARKET, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 91. BRAZIL NIACINAMIDE MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 92. BRAZIL NIACINAMIDE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 93. BRAZIL NIACINAMIDE MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
  • TABLE 94. SAUDI ARABIA NIACINAMIDE MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 95. SAUDI ARABIA NIACINAMIDE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 96. SAUDI ARABIA NIACINAMIDE MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
  • TABLE 97. SOUTH AFRICA NIACINAMIDE MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 98. SOUTH AFRICA NIACINAMIDE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 99. SOUTH AFRICA NIACINAMIDE MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
  • TABLE 100. REST OF LAMEA NIACINAMIDE MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 101. REST OF LAMEA NIACINAMIDE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 102. REST OF LAMEA NIACINAMIDE MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
  • TABLE 103.BROTHER ENTERPRISES HOLDING CO., LTD: COMPANY SNAPSHOT
  • TABLE 104.BROTHER ENTERPRISES HOLDING CO., LTD: OPERATING SEGMENTS
  • TABLE 105.BROTHER ENTERPRISES HOLDING CO., LTD: PRODUCT PORTFOLIO
  • TABLE 106.BROTHER ENTERPRISES HOLDING CO., LTD: NET SALES,
  • TABLE 107.BROTHER ENTERPRISES HOLDING CO., LTD: KEY STRATERGIES
  • TABLE 108.EVONIK INDUSTRIES AG: COMPANY SNAPSHOT
  • TABLE 109.EVONIK INDUSTRIES AG: OPERATING SEGMENTS
  • TABLE 110.EVONIK INDUSTRIES AG: PRODUCT PORTFOLIO
  • TABLE 111.EVONIK INDUSTRIES AG: NET SALES,
  • TABLE 112.EVONIK INDUSTRIES AG: KEY STRATERGIES
  • TABLE 113.FAGRON INC.: COMPANY SNAPSHOT
  • TABLE 114.FAGRON INC.: OPERATING SEGMENTS
  • TABLE 115.FAGRON INC.: PRODUCT PORTFOLIO
  • TABLE 116.FAGRON INC.: NET SALES,
  • TABLE 117.FAGRON INC.: KEY STRATERGIES
  • TABLE 118.FOODCHEM INTERNATIONAL: COMPANY SNAPSHOT
  • TABLE 119.FOODCHEM INTERNATIONAL: OPERATING SEGMENTS
  • TABLE 120.FOODCHEM INTERNATIONAL: PRODUCT PORTFOLIO
  • TABLE 121.FOODCHEM INTERNATIONAL: NET SALES,
  • TABLE 122.FOODCHEM INTERNATIONAL: KEY STRATERGIES
  • TABLE 123.GLOSSIER: COMPANY SNAPSHOT
  • TABLE 124.GLOSSIER: OPERATING SEGMENTS
  • TABLE 125.GLOSSIER: PRODUCT PORTFOLIO
  • TABLE 126.GLOSSIER: NET SALES,
  • TABLE 127.GLOSSIER: KEY STRATERGIES
  • TABLE 128.JUBILANT LIFE SCIENCES LIMITED: COMPANY SNAPSHOT
  • TABLE 129.JUBILANT LIFE SCIENCES LIMITED: OPERATING SEGMENTS
  • TABLE 130.JUBILANT LIFE SCIENCES LIMITED: PRODUCT PORTFOLIO
  • TABLE 131.JUBILANT LIFE SCIENCES LIMITED: NET SALES,
  • TABLE 132.JUBILANT LIFE SCIENCES LIMITED: KEY STRATERGIES
  • TABLE 133.KONINKLIJKE DSM N.V: COMPANY SNAPSHOT
  • TABLE 134.KONINKLIJKE DSM N.V: OPERATING SEGMENTS
  • TABLE 135.KONINKLIJKE DSM N.V: PRODUCT PORTFOLIO
  • TABLE 136.KONINKLIJKE DSM N.V: NET SALES,
  • TABLE 137.KONINKLIJKE DSM N.V: KEY STRATERGIES
  • TABLE 138.LASONS INDIA PVT LTD: COMPANY SNAPSHOT
  • TABLE 139.LASONS INDIA PVT LTD: OPERATING SEGMENTS
  • TABLE 140.LASONS INDIA PVT LTD: PRODUCT PORTFOLIO
  • TABLE 141.LASONS INDIA PVT LTD: NET SALES,
  • TABLE 142.LASONS INDIA PVT LTD: KEY STRATERGIES
  • TABLE 143.LONZA GROUP: COMPANY SNAPSHOT
  • TABLE 144.LONZA GROUP: OPERATING SEGMENTS
  • TABLE 145.LONZA GROUP: PRODUCT PORTFOLIO
  • TABLE 146.LONZA GROUP: NET SALES,
  • TABLE 147.LONZA GROUP: KEY STRATERGIES
  • TABLE 148.MERCK KGAA: COMPANY SNAPSHOT
  • TABLE 149.MERCK KGAA: OPERATING SEGMENTS
  • TABLE 150.MERCK KGAA: PRODUCT PORTFOLIO
  • TABLE 151.MERCK KGAA: NET SALES,
  • TABLE 152.MERCK KGAA: KEY STRATERGIES
  • TABLE 153.VEER CHEMIE: COMPANY SNAPSHOT
  • TABLE 154.VEER CHEMIE: OPERATING SEGMENTS
  • TABLE 155.VEER CHEMIE: PRODUCT PORTFOLIO
  • TABLE 156.VEER CHEMIE: NET SALES,
  • TABLE 157.VEER CHEMIE: KEY STRATERGIES
  • TABLE 158.VERTELLUS: COMPANY SNAPSHOT
  • TABLE 159.VERTELLUS: OPERATING SEGMENTS
  • TABLE 160.VERTELLUS: PRODUCT PORTFOLIO
  • TABLE 161.VERTELLUS: NET SALES,
  • TABLE 162.VERTELLUS: KEY STRATERGIES

LIST OF FIGURES

  • FIGURE 1.NIACINAMIDE MARKET SEGMENTATION
  • FIGURE 2.NIACINAMIDE MARKET,2021-2031
  • FIGURE 3.NIACINAMIDE MARKET,2021-2031
  • FIGURE 4. TOP INVESTMENT POCKETS, BY REGION
  • FIGURE 5.PORTER FIVE-1
  • FIGURE 6.PORTER FIVE-2
  • FIGURE 7.PORTER FIVE-3
  • FIGURE 8.PORTER FIVE-4
  • FIGURE 9.PORTER FIVE-5
  • FIGURE 10.TOP PLAYER POSITIONING
  • FIGURE 11.NIACINAMIDE MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
  • FIGURE 12.PATENT ANALYSIS BY COMPANY
  • FIGURE 13.PATENT ANALYSIS BY COUNTRY
  • FIGURE 14.NIACINAMIDE MARKET,BY TYPE,2021(%)
  • FIGURE 15.COMPARATIVE SHARE ANALYSIS OF POWDER NIACINAMIDE MARKET,2021-2031(%)
  • FIGURE 16.COMPARATIVE SHARE ANALYSIS OF LIQUID NIACINAMIDE MARKET,2021-2031(%)
  • FIGURE 17.COMPARATIVE SHARE ANALYSIS OF OTHERS NIACINAMIDE MARKET,2021-2031(%)
  • FIGURE 18.NIACINAMIDE MARKET,BY APPLICATION,2021(%)
  • FIGURE 19.COMPARATIVE SHARE ANALYSIS OF PHARMACEUTICAL NIACINAMIDE MARKET,2021-2031(%)
  • FIGURE 20.COMPARATIVE SHARE ANALYSIS OF COSMECEUTICAL NIACINAMIDE MARKET,2021-2031(%)
  • FIGURE 21.COMPARATIVE SHARE ANALYSIS OF HUMAN NUTRITION NIACINAMIDE MARKET,2021-2031(%)
  • FIGURE 22.NIACINAMIDE MARKET,BY DISTRIBUTION CHANNEL,2021(%)
  • FIGURE 23.COMPARATIVE SHARE ANALYSIS OF HOSPITAL PHARMACIES NIACINAMIDE MARKET,2021-2031(%)
  • FIGURE 24.COMPARATIVE SHARE ANALYSIS OF ONLINE PHARMACIES NIACINAMIDE MARKET,2021-2031(%)
  • FIGURE 25.COMPARATIVE SHARE ANALYSIS OF DRUG STORES AND RETAIL PHARMACIES NIACINAMIDE MARKET,2021-2031(%)
  • FIGURE 26.NIACINAMIDE MARKET BY REGION,2021
  • FIGURE 27.U.S. NIACINAMIDE MARKET,2021-2031($MILLION)
  • FIGURE 28.CANADA NIACINAMIDE MARKET,2021-2031($MILLION)
  • FIGURE 29.MEXICO NIACINAMIDE MARKET,2021-2031($MILLION)
  • FIGURE 30.GERMANY NIACINAMIDE MARKET,2021-2031($MILLION)
  • FIGURE 31.FRANCE NIACINAMIDE MARKET,2021-2031($MILLION)
  • FIGURE 32.UK NIACINAMIDE MARKET,2021-2031($MILLION)
  • FIGURE 33.ITALY NIACINAMIDE MARKET,2021-2031($MILLION)
  • FIGURE 34.SPAIN NIACINAMIDE MARKET,2021-2031($MILLION)
  • FIGURE 35.REST OF EUROPE NIACINAMIDE MARKET,2021-2031($MILLION)
  • FIGURE 36.JAPAN NIACINAMIDE MARKET,2021-2031($MILLION)
  • FIGURE 37.CHINA NIACINAMIDE MARKET,2021-2031($MILLION)
  • FIGURE 38.AUSTRALIA NIACINAMIDE MARKET,2021-2031($MILLION)
  • FIGURE 39.INDIA NIACINAMIDE MARKET,2021-2031($MILLION)
  • FIGURE 40.SOUTH KOREA NIACINAMIDE MARKET,2021-2031($MILLION)
  • FIGURE 41.REST OF ASIA-PACIFIC NIACINAMIDE MARKET,2021-2031($MILLION)
  • FIGURE 42.BRAZIL NIACINAMIDE MARKET,2021-2031($MILLION)
  • FIGURE 43.SAUDI ARABIA NIACINAMIDE MARKET,2021-2031($MILLION)
  • FIGURE 44.SOUTH AFRICA NIACINAMIDE MARKET,2021-2031($MILLION)
  • FIGURE 45.REST OF LAMEA NIACINAMIDE MARKET,2021-2031($MILLION)
  • FIGURE 46. TOP WINNING STRATEGIES, BY YEAR
  • FIGURE 47. TOP WINNING STRATEGIES, BY DEVELOPMENT
  • FIGURE 48. TOP WINNING STRATEGIES, BY COMPANY
  • FIGURE 49.PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 50.COMPETITIVE DASHBOARD
  • FIGURE 51.COMPETITIVE HEATMAP OF TOP 10 KEY PLAYERS
  • FIGURE 52.BROTHER ENTERPRISES HOLDING CO., LTD.: NET SALES ,($MILLION)
  • FIGURE 53.EVONIK INDUSTRIES AG.: NET SALES ,($MILLION)
  • FIGURE 54.FAGRON INC..: NET SALES ,($MILLION)
  • FIGURE 55.FOODCHEM INTERNATIONAL.: NET SALES ,($MILLION)
  • FIGURE 56.GLOSSIER.: NET SALES ,($MILLION)
  • FIGURE 57.JUBILANT LIFE SCIENCES LIMITED.: NET SALES ,($MILLION)
  • FIGURE 58.KONINKLIJKE DSM N.V.: NET SALES ,($MILLION)
  • FIGURE 59.LASONS INDIA PVT LTD.: NET SALES ,($MILLION)
  • FIGURE 60.LONZA GROUP.: NET SALES ,($MILLION)
  • FIGURE 61.MERCK KGAA.: NET SALES ,($MILLION)
  • FIGURE 62.VEER CHEMIE.: NET SALES ,($MILLION)
  • FIGURE 63.VERTELLUS.: NET SALES ,($MILLION)